Kiran Kumar Mustyala

Identification of novel leads applying<i>in silico</i>studies for Mycobacterium multidrug resistant (MMR) protein

Vasavi Malkhed, Kiran Kumar Mustyala, Sarita Rajender Potlapally et al. · Journal of Biomolecular Structure and Dynamics · 2013 · 21 citations

Life Sciences, Molecular Biology, Pharmacology +17

Homology modeling and virtual screening studies of FGF-7 protein—a structure-based approach to design new molecules against tumor angiogenesis

Rajender Vadija, Kiran Kumar Mustyala, Navaneetha Nambigari et al. · Journal of Chemical Biology · 2016 · 20 citations · Full text

Pharmacy, Molecular Biology, Oncology +17

Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents

Hymavathi Veeravarapu, Vasavi Malkhed, Kiran Kumar Mustyala et al. · Molecular Diversity · 2020 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Molecular dynamic simulations of Co(III) and Ru(II) polypyridyl complexes and docking studies with dsDNA

Navaneetha Nambigari, Ramasree Dulapalli, Kiran Kumar Mustyala et al. · Medicinal Chemistry Research · 2013 · 17 citations

Natural Sciences, Biophysics, Chemistry +14

Pharmacophore mapping and in silico screening to identify new potent leads for A_2Aadenosine receptor as antagonists

Kiran Kumar Mustyala, Annapurna Renee Chitturi, Prameela Subhashini Naikal James et al. · Journal of Receptors and Signal Transduction · 2012 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17